Founded in 2014, Prenetics is a major global diagnostics and genetic testing company with the mission to bring health closer to millions of people globally and decentralize healthcare by making the three pillars — Prevention, Diagnostics and Personalized Care — comprehensive and accessible to anyone, at any time and anywhere.

Prenetics is led by visionary entrepreneur, Danny Yeung, with operations across 9 locations, including the United Kingdom, Hong Kong, India, South Africa, and Southeast Asia. We aim to construct a global healthcare ecosystem to disrupt and decentralize the conventional healthcare system and improve its customers’ wellbeing through comprehensive genetic and diagnostic testing.

On May 18th 2022, Prenetics made international headlines to become Hong Kong’s First Unicorn to publicly list on the Nasdaq with ticker symbol “PRE”.

Prenetics' Vision

The Holy Grail of Healthcare
We aim to build the world’s first full end-to-end health ecosystem.



Our Products